๐Ÿ›๏ธ Verified NIH Record โ€ข Updated 2026-05-22

Investigation of the Interplay Between Local Oral Inflammation, Microbiota and Systemic Immune Responses. (NCT06966492)

๐ŸŸก Not Yet Recruiting Phase4 ๐Ÿ’Š Investigational Drug / Biologic Sponsor: Colgate Palmolive

๐Ÿฉบ Plain-English Summary (8th-Grade Level)

This is a clinical research study designed to measure changes in inflammation and the oral microbiome during a phase of good oral hygiene and the absence of oral hygiene. The goal of the study is to investigate the interplay between local oral inflammation, microbiota and systemic immune responses.

Who can join: Review the eligibility criteria below.

Location: UT Health School of Dentistry โ€” Houston, Texas

Age range: 18 Years to 65 Years

๐Ÿงช Interventions in This Study

๐Ÿ“‹ "Do I Qualify?" โ€” 1-Minute Self Screener

Instant Checklist

Full eligibility criteria are available on the official NIH protocol. View the criteria โ†—

๐Ÿ“ All Participating Trial Locations (1 Sites)

  • UT Health School of Dentistry โ€” Houston, Texas

๐Ÿ“ž Contact the Study Coordinator

Phone: (713) 486-4382

Email: Roger.M.Arce@uth.tmc.edu

Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.

๐Ÿ’ฐ Cost, Insurance & Patient Rights

  • 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
  • Routine Patient Care: Under federal law (ACA ยง 2709) and many state statutes, routine care costs are covered during participation.
  • Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

More studies in Gingival Inflammation

๐Ÿ’ก How to Participate

  1. Check the checklist above to see if you may qualify.
  2. Contact the study coordinator using the phone/email above.
  3. Ask about the visit schedule, what is covered at no cost, and any travel support.
  4. Confirm with your own doctor before making a decision.
๐Ÿ›๏ธ View Official NIH Record โ†—